Literature DB >> 14744468

Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder.

Josephine S Modica-Napolitano1, Perry F Renshaw.   

Abstract

BACKGROUND: A growing body of experimental evidence suggests that mitochondrial dysfunction, including alterations in phospholipid metabolism, might be involved in the pathophysiology of affective illnesses, such as depression and bipolar disorder. The purpose of this study was to determine whether the phosphomonoester phosphoethanolamine (PE) and the lipid metabolite choline (Cho), which are known to be altered in depression and bipolar disorder, and/or their precursors/metabolites, might directly affect mitochondrial bioenergetic function in vitro.
METHODS: To this end, rates of oxygen consumption in freshly isolated, intact mitochondria were determined polarographically in the presence and absence of PE, Cho, ethanolamine (Etn), glycerophosphoethanolamine (GPE), and glycerophosphocholine (GPC).
RESULTS: The data demonstrate that PE and Etn inhibit mitochondrial respiratory activity in a dose-dependent manner, whereas Cho, GPC, and GPE have no measurable effect on bioenergetic function.
CONCLUSIONS: This reflects a specific inhibition by Etn and PE on mitochondrial function rather than a more generalized phenomenon induced by similarities in structure between the lipid metabolites. These results also suggest a possible relationship between mitochondrial dysfunction and altered phospholipid metabolism in the brains of patients with depression and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744468     DOI: 10.1016/s0006-3223(03)00784-4

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  30 in total

Review 1.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

2.  Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Eun-Kee Jeong; Rebekah S Huber; Perry F Renshaw
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

3.  A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.

Authors:  A Villaseñor; A Ramamoorthy; M Silva dos Santos; M P Lorenzo; G Laje; C Zarate; C Barbas; I W Wainer
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

4.  Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia.

Authors:  Gen Yan; Yinghua Xuan; Zhuozhi Dai; Zhiwei Shen; Guishan Zhang; Haiyun Xu; Renhua Wu
Journal:  Neurochem Res       Date:  2014-10-28       Impact factor: 3.996

5.  Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats.

Authors:  Seungwoo Kang; Jing Li; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2017-11-08       Impact factor: 5.250

6.  Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells.

Authors:  Andréa T Faccio; Francisco J Ruperez; Nagendra S Singh; Santiago Angulo; Marina F M Tavares; Michel Bernier; Coral Barbas; Irving W Wainer
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-09       Impact factor: 3.770

7.  Metabolites Associated With Risk of Developing Mobility Disability in the Health, Aging and Body Composition Study.

Authors:  Rachel A Murphy; Steven Moore; Mary Playdon; Stephen Kritchevsky; Anne B Newman; Suzanne Satterfield; Hilsa Ayonayon; Clary Clish; Robert Gerszten; Tamara B Harris
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-01-01       Impact factor: 6.053

8.  Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment.

Authors:  Roopali Saxena; Chunhua Yang; Mukkavilli Rao; Ravi Chakra Turaga; Chakravarthy Garlapati; Sushma Reddy Gundala; Kimberly Myers; Ahmed Ghareeb; Shristi Bhattarai; Golnaz Kamalinia; Sangina Bristi; Dan Su; Giovanni Gadda; Padmashree C G Rida; Guilherme H Cantuaria; Ritu Aneja
Journal:  Clin Cancer Res       Date:  2017-02-06       Impact factor: 12.531

Review 9.  Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Authors:  Maya Kuperberg; Sophie L A Greenebaum; Andrew A Nierenberg
Journal:  Curr Top Behav Neurosci       Date:  2021

10.  Visual aptamer-based capillary assay for ethanolamine using magnetic particles and strand displacement.

Authors:  Mostafa Mahmoud; Stefan Laufer; Hans-Peter Deigner
Journal:  Mikrochim Acta       Date:  2019-10-09       Impact factor: 5.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.